You are here

Sarel-Jacob Fleishman

Prof. Sarel Fleishman. His research has already led to the design of a potential malaria vaccine, and he is now concentrating his efforts on the coronavirus

Weizmann Institute scientists have developed a research platform for designing tiny antibodies that can halt the virus infection process

The molecular structure of Spanish flu protein (hemagglutin) bound to a computationally designed protein (green). The designed protein binds the viral protein tightly and with high specificity, blocking the protein's function and neutralizing viral infectivity

 A new method of redesigning protein molecules may yield novel drugs.

Dr. Sarel-Jacob Fleishman

Dr. Sarel-Jacob Fleishman is the recipient of the Human Frontier Science Program (HFSP) Career Development Award (2012)